(2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide

C31H31F5N6O4 — CID 22984013

IUPAC(2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide
SMILESCCN(CC)CCN1C(=O)C(NC(=O)[C@H](C)NC(=O)COc2c(F)c(F)c(F)c(F)c2F)N=C(c2ccccn2)c2ccccc21
InChIInChI=1S/C31H31F5N6O4/c1-4-41(5-2)14-15-42-20-12-7-6-10-18(20)27(19-11-8-9-13-37-19)39-29(31(42)45)40-30(44)17(3)38-21(43)16-46-28-25(35)23(33)22(32)24(34)26(28)36/h6-13,17,29H,4-5,14-16H2,1-3H3,(H,38,43)(H,40,44)/t17-,29?/m0/s1
InChIKeyWXKJQLIPCSXROK-PLKGVSPESA-N
MW646.62 g/mol
LogP3.33
Rot. Bonds12

About (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide

(2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide (PubChem CID 22984013) has the molecular formula C31H31F5N6O4 and a molecular weight of 646.62 g/mol. Its IUPAC name is (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide.

Molecular Properties

Compound Name(2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide
PubChem CID22984013
Molecular FormulaC31H31F5N6O4
Molecular Weight646.62 g/mol
Exact Mass646.23
IUPAC Name(2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide
SMILESCCN(CC)CCN1C(=O)C(NC(=O)[C@H](C)NC(=O)COc2c(F)c(F)c(F)c(F)c2F)N=C(c2ccccn2)c2ccccc21
InChIInChI=1S/C31H31F5N6O4/c1-4-41(5-2)14-15-42-20-12-7-6-10-18(20)27(19-11-8-9-13-37-19)39-29(31(42)45)40-30(44)17(3)38-21(43)16-46-28-25(35)23(33)22(32)24(34)26(28)36/h6-13,17,29H,4-5,14-16H2,1-3H3,(H,38,43)(H,40,44)/t17-,29?/m0/s1
InChIKeyWXKJQLIPCSXROK-PLKGVSPESA-N
XLogP3.33
TPSA116.23 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds12
Heavy Atoms46
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500646.62
LogP ≤ 53.33
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_2', 'substructure': 'N/A'}

Analyze (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide?
The IUPAC name of (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide (CID 22984013) is (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide.
What is the SMILES notation for (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide?
The canonical SMILES for (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide is CCN(CC)CCN1C(=O)C(NC(=O)[C@H](C)NC(=O)COc2c(F)c(F)c(F)c(F)c2F)N=C(c2ccccn2)c2ccccc21.
What is the InChIKey of (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide?
The InChIKey is WXKJQLIPCSXROK-PLKGVSPESA-N. The full InChI is InChI=1S/C31H31F5N6O4/c1-4-41(5-2)14-15-42-20-12-7-6-10-18(20)27(19-11-8-9-13-37-19)39-29(31(42)45)40-30(44)17(3)38-21(43)16-46-28-25(35)23(33)22(32)24(34)26(28)36/h6-13,17,29H,4-5,14-16H2,1-3H3,(H,38,43)(H,40,44)/t17-,29?/m0/s1.
What are the key properties of (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide?
(2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide has a molecular weight of 646.62 g/mol, XLogP of 3.33, 12 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[1-[2-(diethylamino)ethyl]-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-2-[[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino]propanamide is sourced from PubChem (CID 22984013), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).